| GSE86982 | GSM2317703 | Illumina HiSeq 2500 | Homo sapiens | 54Dn1SK_D11_smart-seq | cultured embryonic stem cells[DCX-][RM165051][viral_barcoded] | days in culture: 54; cre line: DCX-; differentiation#: RM165051; control: FALSE; viral barcoded: viral_barcoded |
| GSE86982 | GSM2317959 | Illumina HiSeq 2500 | Homo sapiens | 54Dp5_D09_smart-seq | cultured embryonic stem cells[DCX+][RM165048] | days in culture: 54; cre line: DCX+; differentiation#: RM165048; control: FALSE |
| GSE86982 | GSM2318215 | Illumina HiSeq 2500 | Homo sapiens | SK_2_C05_smart-seq | cultured embryonic stem cells[RM165095][viral_barcoded] | days in culture: 54; differentiation#: RM165095; control: FALSE; viral barcoded: viral_barcoded |
| GSE52529 | GSM1269018 | Illumina HiSeq 2500 | Homo sapiens | Cell T0_CT_E11 | Human Skeletal Muscle Myoblasts (HSMM) | cell type: Human Skeletal Muscle Myoblasts (HSMM); hour post serum-switch: 0; debris: FALSE; control well: FALSE; cells in well: 1; library protocol: Single-cell |
| GSE57872 | GSM1395403 | Illumina HiSeq 2500 | Homo sapiens | Single cell mRNA-seq_MGH26_A05 | glioblastoma [Pro+Cla] | patient id: MGH26; cell type: Glioblastoma; subtype: Pro+Cla |
| GSE57872 | GSM1395659 | Illumina HiSeq 2500 | Homo sapiens | Single cell mRNA-seq_MGH28_F09 | glioblastoma [Mes] | patient id: MGH28; cell type: Glioblastoma; subtype: Mes |
| GSE57872 | GSM1395915 | Illumina HiSeq 2500 | Homo sapiens | Single cell mRNA-seq_MGH31_D01 | glioblastoma [Pro] | patient id: MGH31; cell type: Glioblastoma; subtype: Pro |
| GSE57872 | GSM1396171 | Illumina HiSeq 2500 | Homo sapiens | Single cell mRNA-seq_CSC8_A05 | gliomasphere CSC8 | cell line: CSC8; cell type: Gliomasphere Cell Line |
| GSE64016 | GSM1562499 | Illumina HiSeq 2500 | Homo sapiens | H1_Exp2.125 | single H1 hESC | cell type: human embryonic stem cells; passages: 30-35; treatment: not sorted |
| GSE64016 | GSM1562764 | Illumina HiSeq 2500 | Homo sapiens | S_Exp1.066 | single H1-Fucci cell sorted from S phase of the cell cycle only | cell type: human embryonic stem cells; passages: 35-40; treatment: FACS sorted |
